American International Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,094
| Closed | -$768K | – | 3149 |
|
|
2021
Q3 | $768K | Sell |
38,094
-488
| -1% | -$13.5K | ﹤0.01% | 1585 |
|
|
2021
Q2 | $1.44K | Sell |
38,582
-13,952
| -27% | -$428K | ﹤0.01% | 1310 |
|
|
2021
Q1 | $1.34K | Sell |
52,534
-1,769
| -3% | -$45.2K | ﹤0.01% | 1312 |
|
|
2020
Q4 | $1.2K | Buy |
54,303
+15,456
| +40% | +$340K | ﹤0.01% | 1296 |
|
|
2020
Q3 | $699K | Sell |
38,847
-883
| -2% | -$18.3K | ﹤0.01% | 1423 |
|
|
2020
Q2 | $1.01M | Buy |
39,730
+8,101
| +26% | +$175K | ﹤0.01% | 1220 |
|
|
2020
Q1 | $581K | Sell |
31,629
-791
| -2% | -$15.4K | ﹤0.01% | 1360 |
|
|
2019
Q4 | $714K | Sell |
32,420
-273
| -0.8% | -$5.49K | ﹤0.01% | 1506 |
|
|
2019
Q3 | $469K | Sell |
32,693
-228
| -0.7% | -$3.26K | ﹤0.01% | 1699 |
|
|
2019
Q2 | $519K | Sell |
32,921
-1,377
| -4% | -$18.7K | ﹤0.01% | 1689 |
|
|
2019
Q1 | $502K | Sell |
34,298
-1,111
| -3% | -$12.8K | ﹤0.01% | 1706 |
|
|
2018
Q4 | $379K | Buy |
35,409
+5,291
| +18% | +$69.6K | ﹤0.01% | 1826 |
|
|
2018
Q3 | $460K | Buy |
30,118
+1,186
| +4% | +$17.3K | ﹤0.01% | 1942 |
|
|
2018
Q2 | $354K | Buy |
+28,932
| New | +$363K | ﹤0.01% | 2040 |
|
|
2016
Q2 | – | Sell |
-8,847
| Closed | -$47K | – | 4671 |
|
|
2016
Q1 | $47K | Hold |
8,847
| – | – | ﹤0.01% | 3912 |
|
|
2015
Q4 | $105K | Sell |
8,847
-16
| -0.2% | -$183 | ﹤0.01% | 3454 |
|
|
2015
Q3 | $73K | Buy |
8,863
+10
| +0.1% | +$115 | ﹤0.01% | 3728 |
|
|
2015
Q2 | $123K | Buy |
8,853
+6,616
| +296% | +$121K | ﹤0.01% | 3490 |
|
|
2015
Q1 | $53.8K | Hold |
2,237
| – | – | ﹤0.01% | 3933 |
|
|
2014
Q4 | $36.8K | Sell |
2,237
-89
| -4% | -$1.03K | ﹤0.01% | 4093 |
|
|
2014
Q3 | $29.6K | Sell |
2,326
-1
| -0% | -$15 | ﹤0.01% | 4196 |
|
|
2014
Q2 | $52.5K | Buy |
+2,327
| New | +$42.2K | ﹤0.01% | 3946 |
|
Other funds holding DRNA
American International Group's DRNA Position: Q4 2021 in Review
American International Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 38,094 shares — an estimated $768K sold.
American International Group first reported a position in DRNA in Q2 2014 and held it in 22 quarters. The position peaked at $1.01M in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- American International Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- American International Group sold 38,094 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $768K.
- American International Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2014 and held it in 22 quarters.
- American International Group's Dicerna Pharmaceuticals, Inc. position peaked at $1.01M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on American International Group's 13F filing for Q4 2021, filed 11 Feb 2022.